Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup
Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks to raise $400 million more VC fun...
America Forever Bytes
Company
Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks to raise $400 million more VC fun...
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
As Trump wages a trade war, American pharma keeps cutting deals with China.
We just covered the Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot.
CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.
Eli Lilly (NYSE:LLY) shares jumped on Thursday morning after securing expanded PBM coverage for its blockbuster obesity treatments, Zepbound and Foundayo.
Eli Lilly announced $3.83 billion push into vaccine acquisitions as TMED rose to top T. Rowe Price's ETF lineup last week.
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lill...
The drugmaker announced it will buy three privately held vaccine makers in deals worth almost $4 billion combined.
Micron Technology joins the $1 trillion club after a historic 19% stock surge. Discover how it overtook giants JPMorgan, Walmart, and Intel.
Chamath Palihapitiya reacted on X after Eli Lilly's VERVE-102 showed strong Phase 1b LDL cholesterol reduction results.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.